Uterotonics (oxytocin, prostaglandin E1/misoprostol, methylergonovine, prostaglandin 15-methyl F2α/carboprost tromethamine, and prostaglandin E2/dinoprostone) are commonly prescribed in PPH management. This evidence concerns the gene OXT and pulmonary arterial hypertension.